{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:47:25Z","timestamp":1791478045481,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004503","name":"Benha University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004503","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40261-024-01401-y","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T07:35:05Z","timestamp":1731310505000},"page":"879-896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients"],"prefix":"10.1007","volume":"44","author":[{"given":"Amira Mohamed","family":"Taha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1643-9750","authenticated-orcid":false,"given":"Ahmed Saad","family":"Elsaeidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Nada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Ghonaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeba","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Ramzy","family":"Mourid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Abouelmagd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"issue":"5","key":"1401_CR1","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/ehf2.12333","volume":"5","author":"CSP Lam","year":"2018","unstructured":"Lam CSP, Doehner W, Comin-Colet J, IRON CORE Group. Iron deficiency in chronic heart failure: case-based practical guidance. ESC Heart Fail. 2018;5(5):764\u201371.","journal-title":"ESC Heart Fail."},{"issue":"1","key":"1401_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","volume":"138","author":"IS Anand","year":"2018","unstructured":"Anand IS, Gupta P. Anemia and iron deficiency in heart failure. Circulation. 2018;138(1):80\u201398.","journal-title":"Circulation"},{"issue":"3","key":"1401_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.15420\/cfr.2019.9.2","volume":"5","author":"N Ebner","year":"2019","unstructured":"Ebner N, von Haehling S. Why is iron deficiency recognised as an important comorbidity in heart failure? Card Fail Rev. 2019;5(3):173\u20135.","journal-title":"Card Fail Rev"},{"issue":"36","key":"1401_CR4","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"18","key":"1401_CR5","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-1032.","journal-title":"Circulation"},{"issue":"1","key":"1401_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ejhf.1838","volume":"23","author":"S von Haehling","year":"2021","unstructured":"von Haehling S, Arzt M, Doehner W, Edelmann F, Evertz R, Ebner N, et al. Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials. Eur J Heart Fail. 2021;23(1):92\u2013113.","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"1401_CR7","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","volume":"136","author":"DJ van Veldhuisen","year":"2017","unstructured":"van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, B\u00f6hm M, Doletsky A, et al. Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation. 2017;136(15):1374\u201383.","journal-title":"Circulation"},{"issue":"372","key":"1401_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29(372): n71.","journal-title":"BMJ"},{"issue":"5","key":"1401_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13643-016-0259-8","volume":"10","author":"L J\u00f8rgensen","year":"2016","unstructured":"J\u00f8rgensen L, Paludan-M\u00fcller AS, Laursen DRT, Savovi\u0107 J, Boutron I, Sterne JAC, et al. Evaluation of the cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in cochrane and non-cochrane reviews. Syst Rev. 2016;10(5):80.","journal-title":"Syst Rev"},{"issue":"14","key":"1401_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"1","author":"CKL Lo","year":"2014","unstructured":"Lo CKL, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol. 2014;1(14):45.","journal-title":"BMC Med Res Methodol"},{"key":"1401_CR11","unstructured":"Deeks J, Higgins J, Altman D, editors. Chapter 10: Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions. version 6.4 (updated August 2023). [cited 2024 Sep 28]. Available from: https:\/\/training.cochrane.org\/handbook"},{"issue":"2","key":"1401_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/ehf2.12250","volume":"5","author":"TJ Yeo","year":"2018","unstructured":"Yeo TJ, Yeo PSD, Hadi FA, Cushway T, Lee KY, Yin FF, et al. Single-dose intravenous iron in Southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF). ESC Heart Fail. 2018;5(2):344\u201353.","journal-title":"ESC Heart Fail."},{"issue":"23","key":"1401_CR13","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.3390\/nu14235057","volume":"14","author":"A Mollace","year":"2022","unstructured":"Mollace A, Macr\u00ec R, Mollace R, Tavernese A, Gliozzi M, Musolino V, et al. Effect of ferric carboxymaltose supplementation in patients with heart failure with preserved ejection fraction: role of attenuated oxidative stress and improved endothelial function. Nutrients. 2022;14(23):5057.","journal-title":"Nutrients"},{"issue":"25","key":"1401_CR14","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436\u201348.","journal-title":"N Engl J Med"},{"issue":"11","key":"1401_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020. Eur Heart J. 2015;36(11):657\u201368.","journal-title":"Eur Heart J"},{"issue":"5","key":"1401_CR16","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2019-0156","volume":"6","author":"S Dhoot","year":"2020","unstructured":"Dhoot S, Mittal S, Singh SP, Patel V, Kasliwal RR, Mehta V. Effect of ferric-carboxy maltose on oxygen kinetics and functional status in heart failure patients with iron deficiency. Future Sci OA. 2020;6(5): FSO467.","journal-title":"Future Sci OA."},{"issue":"48","key":"1401_CR17","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1093\/eurheartj\/ehab411","volume":"42","author":"P Martens","year":"2021","unstructured":"Martens P, Dupont M, Dauw J, Nijst P, Herbots L, Dendale P, et al. The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy-the IRON-CRT trial. Eur Heart J. 2021;42(48):4905\u201314.","journal-title":"Eur Heart J"},{"issue":"11","key":"1401_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","volume":"389","author":"RJ Mentz","year":"2023","unstructured":"Mentz RJ, Garg J, Rockhold FW, Butler J, De Pasquale CG, Ezekowitz JA, et al. Ferric Carboxymaltose in heart failure with iron deficiency. N Engl J Med. 2023;389(11):975\u201386.","journal-title":"N Engl J Med"},{"issue":"9","key":"1401_CR19","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.2215\/CJN.0000000000000223","volume":"18","author":"IC Macdougall","year":"2023","unstructured":"Macdougall IC, Ponikowski P, Stack AG, Wheeler DC, Anker SD, Butler J, et al. Ferric Carboxymaltose in iron-deficient patients with hospitalized heart failure and reduced kidney function. Clin J Am Soc Nephrol CJASN. 2023;18(9):1124\u201334.","journal-title":"Clin J Am Soc Nephrol CJASN."},{"issue":"5","key":"1401_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/ejhf.2491","volume":"24","author":"SD Anker","year":"2022","unstructured":"Anker SD, Ponikowski P, Khan MS, Friede T, Jankowska EA, Fabien V, et al. Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency. Eur J Heart Fail. 2022;24(5):833\u201342.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"1401_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/00015385.2019.1639270","volume":"75","author":"C Arias-Barrera","year":"2020","unstructured":"Arias-Barrera C, Palacios-Ariza MA, Pradilla I, Alvarez-Moreno C. A cohort study of two intravenous treatments for iron deficiency in patients with heart failure. Acta Cardiol. 2020;75(7):605\u201312.","journal-title":"Acta Cardiol"},{"issue":"8","key":"1401_CR22","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/jpm13081250","volume":"13","author":"F Capone","year":"2023","unstructured":"Capone F, Cipriani A, Molinari L, Noale M, Gusella B, Lucente F, et al. Ferric carboxymaltose in patients with acute decompensated heart failure and iron deficiency: a real-life study. J Pers Med. 2023;13(8):1250.","journal-title":"J Pers Med."},{"issue":"1","key":"1401_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ehf2.13753","volume":"9","author":"R L\u00f3pez-Vilella","year":"2022","unstructured":"L\u00f3pez-Vilella R, Lozano-Edo S, Arenas Mart\u00edn P, Jover-Pastor P, Ezzitouny M, Sorolla Romero J, et al. Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction. ESC Heart Fail. 2022;9(1):133\u201345.","journal-title":"ESC Heart Fail."},{"issue":"Suppl C","key":"1401_CR24","doi-asserted-by":"publisher","first-page":"C306","DOI":"10.1093\/eurheartjsupp\/suad054","volume":"25","author":"G Caminiti","year":"2023","unstructured":"Caminiti G, Sposato B, Volterrani M. The role of iron deficiency in heart failure. Eur Heart J Suppl J Eur Soc Cardiol. 2023;25(Suppl C):C306\u20138.","journal-title":"Eur Heart J Suppl J Eur Soc Cardiol."},{"issue":"4","key":"1401_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013;165(4):575-582.e3.","journal-title":"Am Heart J"},{"issue":"27","key":"1401_CR26","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"19","key":"1401_CR27","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1001\/jama.2017.5427","volume":"317","author":"GD Lewis","year":"2017","unstructured":"Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA. 2017;317(19):1958\u201366.","journal-title":"JAMA"},{"issue":"9","key":"1401_CR28","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.3390\/nu5093730","volume":"5","author":"N Ebner","year":"2013","unstructured":"Ebner N, von Haehling S. Iron deficiency in heart failure: a practical guide. Nutrients. 2013;5(9):3730\u20139.","journal-title":"Nutrients"},{"issue":"1","key":"1401_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ejhf.823","volume":"20","author":"SD Anker","year":"2018","unstructured":"Anker SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F, et al. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail. 2018;20(1):125\u201333.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1401_CR30","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1002\/ehf2.13146","volume":"7","author":"MS Khan","year":"2020","unstructured":"Khan MS, Usman MS, von Haehling S, Doehner W, Stewart Coats AJ. Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis. ESC Heart Fail. 2020;7(6):3392\u2013400.","journal-title":"ESC Heart Fail."},{"issue":"6","key":"1401_CR31","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ihj.2017.10.009","volume":"69","author":"J Dalal","year":"2017","unstructured":"Dalal J, Katekhaye V, Jain R. Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: a meta-analysis. Indian Heart J. 2017;69(6):736\u201341.","journal-title":"Indian Heart J"},{"issue":"7","key":"1401_CR32","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/ejhf.2860","volume":"25","author":"SD Anker","year":"2023","unstructured":"Anker SD, Khan MS, Butler J, von Haehling S, Jankowska EA, Ponikowski P, et al. Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: a Bayesian meta-analysis. Eur J Heart Fail. 2023;25(7):1080\u201390.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"1401_CR33","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/ejhf.2270","volume":"23","author":"P McEwan","year":"2021","unstructured":"McEwan P, Ponikowski P, Davis JA, Rosano G, Coats AJS, Dorigotti F, et al. Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF. Eur J Heart Fail. 2021;23(10):1687\u201397.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"1401_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3111\/13696998.2015.1029491","volume":"18","author":"T Hofmarcher","year":"2015","unstructured":"Hofmarcher T, Borg S. Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden. J Med Econ. 2015;18(7):492\u2013501.","journal-title":"J Med Econ"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-024-01401-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-024-01401-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-024-01401-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T10:09:26Z","timestamp":1733998166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-024-01401-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1401"],"URL":"https:\/\/doi.org\/10.1007\/s40261-024-01401-y","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"14 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.M.T. conceived the idea. A.M.T. designed the research workflow. S.A.N., S.S., M.M.G., A.A., M.R.M. and K.A. searched the databases. S.A.N., S.S., M.M.G., A.A., M.R.M. and K.A. screened the retrieved records, extracted relevant data, assessed the quality of evidence, and A.M.T. and A.S.E. resolved the conflicts. A.A. performed the analysis. A.S.E., S.A.N., S.S., M.M.G., A.A., M.R.M., and K.A. wrote the final manuscript. A.M.T. and A.S.E. supervised the project. All authors have read and agreed to the final version of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"We received no funding for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}